Abstract
High-dose chemotherapy (HDC) with hematopoietic progenitor cell transplantation is a standard option for relapsed/refractory testicular germ-cell tumor (GCT), but only few data have been reported in female patients with GCT. We conducted a retrospective analysis of female patients with GCT treated with HDC and registered with the European Society for Blood and Marrow Transplantation. Between 1985 and 2013, 60 registered female patients with GCT, median age 27 years (range 15-48), were treated with salvage HDC. Forty patients (67%) had primary ovarian GCT, 8 (13%) mediastinal, 7 (12%) retroperitoneal and 5 (8%) other primary sites/unknown. Twenty-two patients (37%) received HDC as second-line therapy, 29 (48%) as third-line, and 9 (15%) as fourth- to sixth-line. Nine of 60 patients (15%) received HDC as late-intensification with no evidence of metastasis before HDC. The conditioning HDC regimens comprised carboplatin in 51 of 60 cases (85%), and consisted of a single HDC cycle in 31 cases (52%), a multi-cycle HDC regimen in 29 (48%). Nine cases who underwent late intensification HDC were not evaluable for response. Of the other 51 assessable patients, 17 (33%) achieved a complete response (CR), 8 (16%) a marker-negative partial ...Continue Reading
References
Jul 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C R NicholsS N Wolff
Feb 1, 1995·Cancer·J P LotzV Izrael
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
May 12, 2001·American Journal of Obstetrics and Gynecology·A NawaN Nakashima
Jul 19, 2002·Cancer·Giovanni RostiMaurizio Marangolo
Nov 2, 2004·Bone Marrow Transplantation·G RostiUNKNOWN Solid Tumours Working Party
Dec 16, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U De GiorgiUNKNOWN Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation
Aug 18, 2005·British Journal of Cancer·U De GiorgiUNKNOWN European Group for Blood and Marrow Transplantation Solid Tumours and Paediatric Disease Working Parties
Oct 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nirupa MurugaesuMichael J Seckl
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Darren R FeldmanRobert J Motzer
Oct 20, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN International Prognostic Factors Study GroupChristian K Kollmannsberger
Mar 30, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anja LorchJörg Beyer
Jan 19, 2012·Cancer·Ramandeep S AroraJillian M Birch
Nov 16, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J BeyerC Wittekind
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Natraj Reddy AmmakkanavarLawrence H Einhorn
Jun 28, 2015·Gynecologic Oncology·Jane L MeiselDarren R Feldman
Feb 14, 2016·Gynecologic Oncology·Christine G SimoneDon S Dizon
Nov 22, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nabil AdraLawrence H Einhorn
Dec 21, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A F LearyUNKNOWN participants of the Fifth Ovarian Cancer Consensus Conference
Citations
Jun 4, 2020·Cancers·Asaf MaozDavid M Gershenson
Jul 6, 2018·Sarcoma·Pavan TennetiFaiz Anwer
Oct 20, 2019·Cancers·Ugo De GiorgiGiorgia Mangili
Mar 22, 2020·Archives of Gynecology and Obstetrics·Jinhui WangLina Guo
Jul 7, 2020·Gynecologic Oncology·F DerquinT de La Motte Rouge